Oct 19, 2026 06:59AM
Oct 13, 2026 08:59AM
Oct 12, 2026 06:55AM
Oct 12, 2026 06:55AM
Oct 12, 2026 06:50AM
Oct 12, 2026 06:50AM
Oct 8, 2026 07:12AM Bristol-Myers Squibb Co. (BMY) PT Lowered to $53 at Cantor Fitzgerald on Anticipated Milvexian Pressure
Oct 8, 2026 06:59AM
Oct 8, 2026 06:59AM
Sep 30, 2026 05:32PM
Sep 30, 2026 05:32PM
Sep 25, 2026 10:00AM
Sep 25, 2026 10:00AM
Sep 18, 2026 06:59AM Bristol Myers Squibb to Report Results for Third Quarter 2026 on October 29, 2026
Sep 17, 2026 06:59AM
Sep 17, 2026 06:59AM
Sep 17, 2026 06:00AM
Sep 8, 2026 06:59AM
Sep 8, 2026 06:59AM
Aug 31, 2026 06:05AM
Aug 29, 2026 11:00AM Bristol Myers Squibb Presents Data Up to Five Years Reinforcing the Long-Term Efficacy and Safety of Camzyos (mavacamten) in Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) at the European
Aug 13, 2026 05:12PM
Aug 13, 2026 05:12PM
Aug 10, 2026 09:02AM
Aug 10, 2026 09:01AM
Aug 5, 2026 08:31AM
Aug 3, 2026 11:24AM
Aug 1, 2026 10:00AM U.S. biopharma earnings: Eli Lilly (LLY), Pfizer (PFE) take the stage
Jul 30, 2026 07:25AM
Jul 30, 2026 07:00AM
Jul 30, 2026 06:59AM
Jul 20, 2026 06:59AM
Jul 20, 2026 06:59AM
Jul 13, 2026 06:59AM
Jul 13, 2026 06:59AM U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma
Jun 18, 2026 06:59AM
Jun 2, 2026 08:02AM
Jun 2, 2026 08:00AM
Jun 1, 2026 06:59AM
Jun 1, 2026 06:59AM
Jun 1, 2026 06:56AM
Jun 1, 2026 06:55AM Bristol Myers Squibb Announces Opdivo® (nivolumab) in Combination with AVD Receives Expanded EU Label with Approval in Frontline Advanced Classical Hodgkin Lymphoma
May 29, 2026 08:02AM
May 29, 2026 08:00AM
May 21, 2026 05:01PM
May 21, 2026 05:01PM
May 20, 2026 06:59AM
May 20, 2026 06:59AM
May 8, 2026 07:00AM Bristol Myers Squibb gets EU approval for Sotyktu to treat psoriatic arthritis
May 8, 2026 06:59AM

1,231,808 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All